chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediately after receiving injection developed itchy roof of mouth, lightheadedness, "throat swelled shut".  EMTs called, transported to Hospital where she received steroids and ibuprofen.  She also used her asthma inhaler.  Symptoms improved slowly but still had wheezing for several days. She was released from the ER after several hours.
Nausea Extreme tiredness Body Ache Chills Fever. 100f
Hospitalized with covid after vaccine.  Breakthrough case, Increased shortness of breath, dx of PE
I am experience nasal pressure in side my nose.  I experienced this with the first shot on March 13 about 30 minutes later.  Today I felt the same pressure about 5 minutes after receiving my booster.  I didn?t have this reaction with the second shot.  The first and second shot I received in the left arm; while the booster I took in the right arm.
Site: Pain at Injection Site-Severe, Systemic: arm pain-Severe, Systemic: Joint Pain-Severe, Additional Details: Pt called stating she thinks the vaccine was given too high, cause her immense pain and she had to visit the urgent care. Arm is now in a sling and patient is taking tylenol #3 for the pain.
Headache, Myalgia, Fever, 6hrs after injection: arm pain, on 1/27- fever chills,  on 1/28 - fatigue, headaches. Narrative:  Other Relevant History:
Hx: TIA and ?blockage to aorta 10 years ago?  Pt arrived to clinic for Covid-19 Vaccine, first dose.  Allergy to cilantro-anaphylaxis, and Demerol-convulsions.  11:30 Patient had her first Covid-19 Pfizer vaccine dose.   11:55 Pt c/o frontal headache pain that is different than her typical migraine pain, history of migraines. Pt also c/o weakness. Pt appears weak, pt in seated position in chair with legs elevated on nearby chair, husband at pt side.  11:56  Pharm at pt side. Several student Nurses at pt side, and  RN at pt side. Vitals: BP 110/62, HR 94, RR 23, 99%. EMS called by  Pharm 11:57 Brief neuro exam, Pt following commands, equal grips, equal strength in upper extremities, equal strength in lower extremities, speech clear, coherent and logical, eyes equal round and responsive upon command. PT c/o nausea and vomiting. No emesis 12:05 EMS arrived report given to EMS by  Pharm. EMS BP 170/84. 12:11 PT agreed to go to ED via EMS, pt exited clinic via gurney with EMS, pt alert and oriented at time of departure.
Inspection for rashes, lesions, ulcers -- Pt is having 1-2 cm erythematous induration on right deltoid area, where he received VARIVAX yesterday. No abscess.
Case number PHEH2014US018203, is an initial spontaneous report from a pharmacist received on 09 Sep 2014. This report refers to a 41-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. She was vaccinated with FLUVIRIN (batch number: 145205) intramuscularly at a dose of 0.5 ml on 29 Aug 2014. It was reported that the FLUVIRIN received by her was stored at 49 F for two hours. No adverse event was reported following the medication errors.
Sedation, Myalgia, Arthralgia, fatigue, pain at the injection site Narrative:
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with a dose of RECOMBIVAX HB (lot # J007946, expiration date 24-MAR-2016, lot # J014855 expiration date 16-APR-2016, lot # K008334,  expiration date 09-JUN-2016 (dose and route were not reported). No co-suspect and concomitant therapies were reported. The nurse reported that Department of Health requested glycol thermometer readings that showed improper storage of the vaccine. Doses of vaccine may have been administered to an unspecified number of patients on unspecified dates. Nurse also stated according to the Sensitronic thermometer there had not been a temperature excursion in this refrigerator. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
had both vaccines, then got shingles/Suspected vaccination failure; shingles/ then got shingles/ last episode was very minor; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 8-Oct-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient had similar experiences. The patient had both vaccines and then got shingles. The patient stated that last episode was very minor. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Patient noted pain at injection site the day after injection.  That immediate acute pain resolved in 1 day.  Approximately 2 weeks after vaccination, patient noted left arm weakness and decreased range of motion.    At time of entering this report (8 months after injection), patient still has ongoing arm weakness and decreased range of motion.
Numbness around mouth (whole mouth including upper and lower lips) as she had received lidocaine, started 15 min after the vaccine and lasted 4 hours. There no other symptoms
Nausea and vomiting, and muscle aches with dizziness. Pt reports no faiting, trouble breathing or rash/hives.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site warmth in a 75-year-old female patient who receive SHINGRIX (batch number 9XC39, expiry date unknown. On 18th January 2018, the patient received SHINGRIX. In January 2018, less than a week after receiving SHINGRIX, the patient experienced injection site warmth, injection site pain, injection site erythema and injection site reaction. The patient was treated with NSAID's and non-drug therapy (Cold Compress). On an unknown date, the outcome of the injection site warmth, injection site pain and injection site erythema were recovered/resolved and the outcome of the injection site reaction was unknown. The reporter considered the injection site warmth, injection site pain and injection site erythema to be related to SHINGRIX. It was unknown if the reporter considered the injection site reaction to be related to SHINGRIX. Additional details were reported as follows: The patient experienced an injection site reaction described as heat, redness, and soreness at the injection site. On day 5 or 6, the patient visited to the pharmacy with a worsening of her symptoms. The patient used NSAIDs and a cold compress as treatment. The pharmacist stated the patient also reported tightness in addition to the other symptoms. The healthcare professional and patient reported tightness in addition to the other symptoms. The healthcare professional and patient reported adverse event through VAERS. No further details were provided regarding the report of tightness. No further medical intervention or physician's visit was required. This was 1 of 3 cases, reported by the same reporter.
Patient had the Moderna vaccine and couldn't walk afterwards; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (Patient had the Moderna vaccine and couldn't walk afterwards) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced GAIT INABILITY (Patient had the Moderna vaccine and couldn't walk afterwards). At the time of the report, GAIT INABILITY (Patient had the Moderna vaccine and couldn't walk afterwards) outcome was unknown.            No concomitant medication information was provided. No treatment information was provided.   Reporter did not allow further contact
her pain has diminished.; she wakes up with her back muscles exhausted; her muscles continue to bhe bad; she wakes up with fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (her pain has diminished.), MUSCLE FATIGUE (she wakes up with her back muscles exhausted), MYALGIA (her muscles continue to bhe bad) and FATIGUE (she wakes up with fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (her pain has diminished.), MUSCLE FATIGUE (she wakes up with her back muscles exhausted), MYALGIA (her muscles continue to bhe bad) and FATIGUE (she wakes up with fatigue). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (her pain has diminished.), MUSCLE FATIGUE (she wakes up with her back muscles exhausted), MYALGIA (her muscles continue to bhe bad) and FATIGUE (she wakes up with fatigue) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       the patient said she was still in treatment, she hadn't been able to work and she had been at home. she said that from a scale of 1to 10, to feel better she was at 4. No concomitant product use was reported
Initial information received on 10-Aug-2018 regarding an unsolicited valid serious case received from a Consumer (physician). This case involves Adult male patient (age unknown) who experienced optic neuritis, while he received vaccine FLUZONE QUADRIVALENT. The patient's past medical history, concomitant medication and family history were not provided. On 01-Dec-2017, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UT5934NA, expiry date 30 Jun 2018 via intramuscular route in the left deltoid. On an unspecified date (reported as 11-Dec-2017 or 12-Dec-2017), the patient developed a serious optic neuritis with 12 or 13 days following the administration of INFLUENZA QUADRIVAL A-B VACCINE. This event was assessed as medically significant. On an unspecified date (reported as 11-Dec-2017 or 12-Dec-2017), the patient developed a serious pain with eye movement with 12 or 13 days following the administration of INFLUENZA QUADRIVAL A-B VACCINE. This event was assessed as medically significant. On an unspecified date (reported as 11-Dec-2017 or 12-Dec-2017), the patient developed a serious scotoma in the central field of his left eye with 12 or 13 days following the administration of INFLUENZA QUADRIVAL A-B VACCINE. This event was assessed as medically significant. Other relevant tests included - On an unknown date, all tests for Multiple sclerosis were negative. Final diagnosis was optic neuritis. The patient was treated with 1000 mg of SOLU-MEDROL IV for 3 days, then 100 mg Prednisone for 11 days, 50 mg prednisone for 1 day and 25 mg prednisone for 2 days. The patient outcome is reported as Recovered / Resolved on an unknown date for optic neuritis, as Recovered/Resolved on an unknown date for pain with eye movement and as Recovered/Resolved on an unknown date for scotoma in the central field of his left eye. Took 5-6 weeks for his symptoms to resolve. List of documents held by sender - none. Sender's Comments: This case concerns an adult patient who developed optic neuritis after vaccination with FLUZONE QUADRIVALENT. The time to onset is compatible. All tests for Multiple sclerosis were negative. The patient's medical condition at the time of vaccination, and past history were not provided. Based upon the reported information, the role of the vaccine cannot be assessed.
Approximately 2 weeks after receiving  my 2nd dose of Pfizer vaccine, my the top half of my right hand went numb.  Around the same time, I lost approximately two-thirds of the strength in my right shoulder.   There were no injuries or pain associated with these issues.  The numbness in my hand persisted for approximately 45 days before returning to normal.  The lack of strength in my right shoulder started to improve gradually after 45 days but continued to persist.  In October I injured the left shoulder in an accidental fall at my home while performing chores at a low height on a ladder.  I don't believe that this accident would have resulted in any significant injury had my shoulder be in its healthy, pre-vaccination condition,  as I was previously in a 6 days a week rotation of aerobic and strength training and was very physically fit in my upper body and shoulder area.  I continue to suffer from pain in my right shoulder.  I have received a steroid injection and numerous physical therapy sessions for this health issue.
Tinnitus in her left ear; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced TINNITUS. At the time of the report, TINNITUS outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment information was not reported.
h/a began 4-6hr p/vax;eyes began aching @ same time day p/got nausea, sore throat w/cont h/a & eye aching;then hives on face occurred same day;pt took DPH 3 days missed work 1 day;
Wed 29 Feb 12 - Received Flu shot. Mon 19 March 12 - Received Tdap vaccine. About Thurs 22 March 12 - Dizzy & visual disturbance. Mon 9 April 12 - To ED & admit. Tues 10 April 12 - Transfer to another hospital by ambulance. DX: Acute Disseminated Encephalomyelitis. W or Th 18 or 19 April - back home.
H1N1 vaccine administration done in the school.  Child developed rash on face.  One 25mg Benadryl administered.  Child taken to health room.  Parent notified and to pick up student
p/vax pt T103.8 & was achy also c/o sore throat & h/a;given APAP & temp went down;c/o joint pain in all joint including fingers;
Low grade fever, swollen lymph nodes under vaccinated arm,  headache, fatigue, and ?vaccination arm? that is red, swollen, itchy, painful,  that covers the front of most of upper arm.
Induration of 60 cm at DT booster site within 24 hours after receiving booster. Benadryal OTC. Woke up next morning noticing reaction.
Injection site red - puffy 5 to 6 inch diameter hot to touch, tender, as of yet still getting bigger (spreading).
I received the J&J single shot Covid vaccine yesterday on 8/30/21 at 2PM CST. Five hours later (at 7PM CST) I noticed a rash/bruising on my arm near the injection site and in 4 other areas on both arms. By 11PM on 8/30/21, approximately 7 hours after the shot, I felt like I had full blown influenza. My greatest concern is the large allergic reaction/bruise/rash on my arms. Again, reaction is primarily near the injection site, but at least in 4 other areas on my arms that were not there when I got the vaccine. None of these bruises/rashes were present prior to the vaccine. The areas of rash can only be explained by the effects of the injection. 48 hours post injection the rash remains.
My arm was tingling and sore to the touch and when moving. The non-injection arm was also tingling. I felt dizzy and spacey, like a far away feeling, almost like a disorientation. I had a headache as well, and was extremely fatigued.   I also got my period 7 days early, when my period has been on a  28 cycle for about 10 years. There are also cysts on my ovaries now.
Circumstance or information capable of leading to medication error; no adverse event; another patient who had been administered but HCP is still verifying; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (another patient who had been administered but HCP is still verifying), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (no adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7184B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Jul-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 11-Jul-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (another patient who had been administered but HCP is still verifying). On an unknown date, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (another patient who had been administered but HCP is still verifying), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (another patient who had been administered but HCP is still verifying) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error).    No concomitant medication was reported.  The date vial was first puncture on 10-JUL-2023. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-733054 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-733054:Same reporter, Same product, Same Batch lot/number
Severe pain in arm, swelling and severe redness from shoulder to elbow, hot to the touch.  Fever, flu-like symptoms (aches), and trouble breathing.  This lasted for over 24 hours.  Slept a good portion of the next day.
Immediately after receiving I began itching first face, neck, head, eyes followed by whole entire body itching along with my heart rate increased and flushing  then  hives started all over my entire body  about 1/2-45 minutes after receiving then by 1 -2 hours after receiving I developed blisters in my scalp followed by my abdomen, back, arms, toes.  The hives, itching and blisters lasted about 5 days. I was given Benadryl 25mg right away and then given another 25 mg about 15 minutes later by the Pharmacist who administered the vaccine. I was told to take another 50 mg of Benadryl in 1 hour and if I get worse to call 911 and go to the hospital immediately. I had to keep taking Benadryl for the next 4 days around the clock.
Rash on her arms; Skin reaction; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Apr-2021 and was forwarded to Moderna on 29-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SKIN REACTION (Skin reaction) and RASH (Rash on her arms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN REACTION (Skin reaction) and RASH (Rash on her arms). At the time of the report, SKIN REACTION (Skin reaction) and RASH (Rash on her arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications taken by the patient were not provided. Treatment information was not provided.
She got her vaccine, had a headache on 7/3/23, and felt a little dizzy.  Then she had blood pressure issues and went to the UC for that, but had never had an issues, it was 154/90 on 7/18/23.  It was 157/97 at one point as well.  They did not give her any medicine in the UC and was to take Tylenol for her headache.  She went to the doctor the next day and her BP was OK that day.  Her PCP sent her to a cardiologist for an Echocariogram and it was OK.  Then about 3 weeks ago she had a rash that spread from her left arm to her right arm, and felt that she may have cut herself, allergic to her detergent, or poison ivy.  She took Caladryl and Cortisone.  She went to a dermatologist to find out what it was, and shedid not and she did not know what it was, told her it was not shingles as she would not have it on both arms.  She now has scars from the rash itself now that they have healed up and hopes she does not have them for the rest of her life.  She told her that if it did not go away then to come in for a biopsy.  She gave her some cream to put on it and that dried up the areas.  Her arm stayed sore for about 2 weeks.  All these things after she got the shingle shot, and didn't think about it until she broke out.